| |NOVEMBER 20246Venus Remedies Gains PIC/S GMP Approval for Robotic Syringe FacilityHuidaGene's First CRISPR RNA-Editing Therapy for nAMD Cleared by US FDAUS FDA Approves Protega Pharma's RoxybondChip Assisted Brain Tumor Surgery to Undergo Clinical TrialsCONTENT010203040809TOP STORIESPANORAMAA Paradigm Shift in Healthcare: How Regenerative Medicine is Changing Treatment10QR LIFE SCIENCESHelping Patients Once Again Lead Pain-free, Happier Lives through its Proprietary QRST TechnologySidharth Bhandari Founder & ChairmanYash Vardhan Bhandari Chief Operating Officer
<
Page 5 |
Page 7 >